Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Online pharmacies in England, Wales, and Scotland will have to carry out stricter checks on people who are buying weight loss drugs, under new regulatory guidance. Pharmacists will no longer be able ...

From Aug. 1 to the end of the year, Medicaid beneficiaries received 33,035 claims for GLP-1 drugs for weight loss, a number ...

This translates to a total mean weight loss of 9 lbs (4.1 kg ... alert – from the WHO regarding increasing reports of falsified semaglutide since 2022. Falsified GLP1-RA drug products have the ...